Applications of artificial intelligence in cardiovascular risk detection and prediction among adults with obesity: a scoping review - Top-Institutions - MDSpire

Applications of artificial intelligence in cardiovascular risk detection and prediction among adults with obesity: a scoping review

  • By

  • Mario Andrés Torres Torres

  • Mariana González Garcés

  • Jerónimo Cárdenas Montoya

  • Valeria Concha Fernández

  • Erwin Hernando Hernández Rincón

  • May 12, 2026

  • 0 min

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, Minnesota

    Key Differentiators

    • Cardiology
    • Artificial Intelligence

  • #2

    Cedars-Sinai Medical Center
    Cedars-Sinai Medical Center

    Los Angeles, California

    Key Differentiators

    • Cardiology
    • Heart & Vascular Surgery

  • #3

    National Heart and Lung Institute, Imperial College London
    National Heart and Lung Institute, Imperial College London

    London, England

    Key Differentiators

    • Cardiology

  • #4

    Royal Brompton and Harefield Hospitals
    Royal Brompton and Harefield Hospitals

    London, England

    Key Differentiators

    • Cardiology

  • #5

    University of Zurich
    University of Zurich

    Zurich, Switzerland

    Key Differentiators

    • Cardiology

Original Source(s)

Applications of artificial intelligence in cardiovascular risk detection and prediction among adults with obesity: a scoping review

  • by Mario Andrés Torres Torres, Mariana González Garcés, Jerónimo Cárdenas Montoya, Valeria Concha Fernández, Erwin Hernando Hernández Rincón

  • May 12, 2026

Related Content

Association Between Metabolic Clusters and Microbial Age in High-Risk Populations for Diabetes and Their Potential Impact on Cardiovascular Disease Risk: Cross-Sectional Observational Study

Top 10 States for Physician-Owned Hospitals

These 10 states make it more practical for physicians to participate in hospital ownership by aligning statutory structure, corporate practice of medicine rules, and population trends.

Ensitrelvir Reduced COVID After Household Exposure

In SCORPIO-PEP, symptomatic COVID-19 occurred in 3% vs 9% of household contacts by day 10.